Vicore Pharma Investor Relations Material
Latest events
Investor Update
Vicore Pharma
Investor Presentation
5 Jun, 2025
Q1 2025
6 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vicore Pharma Holding
Access all reports
Vicore Pharma Holding, a clinical-stage biopharmaceutical company, develops pharmaceutical products for the treatment of orphan lung diseases.
Key slides for Vicore Pharma Holding
Investor Presentation
Vicore Pharma Holding
Investor Presentation
Vicore Pharma Holding
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
VICO
Country
🇸🇪 Sweden